Divergent Findings With Paclitaxel and Nab-Paclitaxel in TNBC Divergent Findings With Paclitaxel and Nab-Paclitaxel in TNBC

Certain patients with triple-negative breast cancer (TNBC) may benefit when atezolizumab is combined with nab-paclitaxel but not with paclitaxel, a pair of phase 3 trials suggest.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news